Ac2-26 TFA (151988-33-9 free base) TP1321
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-_B and MAPK pathways in the injured lung tissue.
CAS nr:
TP1321
Purity:
98%
Molecular Weight:
3203,45
SMILES:
Formula:
C143H211F3N32O46S
Pathway:
Target:
